Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 14
2013 17
2014 9
2015 9
2016 8
2017 14
2018 18
2019 14
2020 15
2021 9
2022 11
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of TM5614 in combination with paclitaxel in the treatment of paclitaxel-resistant cutaneous angiosarcoma: Phase II study protocol.
Fujimura T, Yoshino K, Nakamura M, Kato H, Ito T, Maekawa T, Fujisawa Y, Matsushita S, Amagai R, Yamazaki E, Takahashi M, Tamabuchi E, Hashimoto A, Kambayashi Y, Yamazaki N, Miyata T, Asano Y. Fujimura T, et al. Among authors: kambayashi y. Exp Dermatol. 2024 Jan;33(1):e14976. doi: 10.1111/exd.14976. Epub 2023 Nov 9. Exp Dermatol. 2024. PMID: 37946551
Adverse events associated with postoperative outcomes of adjuvant anti-PD-1 antibody therapy in both acral and non-acral cutaneous melanomas: A multicenter, observational, post hoc analysis study.
Muto Y, Kambayashi Y, Kato H, Fukushima S, Ito T, Maekawa T, Fujisawa Y, Yoshino K, Uchi H, Matsushita S, Yamamoto Y, Amagai R, Ohuchi K, Hashimoto A, Asano Y, Fujimura T. Muto Y, et al. Among authors: kambayashi y. J Dermatol. 2024 Mar;51(3):458-462. doi: 10.1111/1346-8138.16912. Epub 2023 Jul 30. J Dermatol. 2024. PMID: 37518979
Postoperative adjuvant therapy for 120 patients with melanoma, including acral and mucosal subtypes: a multicentre, observational study of 2-year follow-up results.
Muto Y, Kambayashi Y, Kato H, Fukushima S, Ito T, Maekawa T, Shoichiro I, Uchi H, Matsushita S, Yamamoto Y, Yoshino K, Fujisawa Y, Amagai R, Ohuchi K, Hashimoto A, Asano Y, Fujimura T. Muto Y, et al. Among authors: kambayashi y. Br J Dermatol. 2023 Sep 15;189(4):476-478. doi: 10.1093/bjd/ljad183. Br J Dermatol. 2023. PMID: 37243542 No abstract available.
135 results